Last reviewed · How we verify
Staphylococcal pharyngitis
Approved treatments
- Amoxycillin · King George's Medical University
- Amoxil · Generic (originally Beecham/GSK)
Broad-spectrum aminopenicillin that inhibits bacterial cell wall synthesis by binding penicillin-binding proteins. - Amoxicilli · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Staphylococcal pharyngitis patent landscape — cliff calendar, originator estates, attackable patents
- Staphylococcal pharyngitis treatment landscape brief
- Staphylococcal pharyngitis treatment updates RSS
Frequently asked questions about Staphylococcal pharyngitis
What drugs treat Staphylococcal pharyngitis?
Tracked treatments include Amoxycillin, Amoxil, Amoxicilli.
What is the treatment for Staphylococcal pharyngitis?
Standard treatment for Staphylococcal pharyngitis includes Amoxycillin, Amoxil, Amoxicilli. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Staphylococcal pharyngitis patent cliff · Staphylococcal pharyngitis CI report
- Treatment: Amoxycillin · King George's Medical University
- Treatment: Amoxil · Generic (originally Beecham/GSK)
- Treatment: Amoxicilli · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing